Functional genomics screening identifies aspartyl‐ <scp>tRNA</scp> synthetase as a novel prognostic marker and a therapeutic target for gastric cancers-Reference-Cited by-同舟云学术

Functional genomics screening identifies aspartyl‐ tRNA synthetase as a novel prognostic marker and a therapeutic target for gastric cancers

Published:2022-07-11 Issue:2 Volume:258 Page:106-120
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:The Journal of Pathology

Author:

Liu Bin¹,Katoh Hiroto²^ORCID,Komura Daisuke²^ORCID,Yamamoto Asami²,Ochi Mieko²,Onoyama Takumi²,Abe Hiroyuki³,Ushiku Tetsuo³,Seto Yasuyuki⁴,Suo Jian¹,Ishikawa Shumpei²^ORCID

Affiliation:

1. Department of Gastrocolorectal Surgery The First Hospital of Jilin University Changchun PR China

2. Department of Preventive Medicine, Graduate School of Medicine The University of Tokyo Tokyo Japan

3. Department of Pathology, Graduate School of Medicine The University of Tokyo Tokyo Japan

4. Department of Gastrointestinal Surgery, Graduate School of Medicine The University of Tokyo Tokyo Japan

Funder

Precursory Research for Embryonic Science and Technology

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5980

Reference57 articles.

1. Global Incidence and Mortality of Gastric Cancer, 1980-2018

2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

3. Lifestyles, genetics, and future perspectives on gastric cancer in east Asian populations

4. Prognostic value of diffuse versus intestinal histotype in patients with gastric cancer: a systematic review and meta-analysis

5. Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DARS expression in BCR/ABL1-negative myeloproliferative neoplasms and its association with the immune microenvironment;Scientific Reports;2024-07-19

2. NIFK as a potential prognostic biomarker in colorectal cancer correlating with immune infiltrates;Medicine;2023-10-06

3. Advancing gastric cancer precision medicine with novel genomic screens ^†;The Journal of Pathology;2023-01-27